-

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Community Health Systems, Inc. (CYH)

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Community Health Systems, Inc. (“Community Health” or the “Company”) (NASDAQ:CYH). The investigation concerns whether Community Health and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

[Click here to learn more about the investigation]

On February 21, 2024, Community Health disclosed that it was under investigation by the Department of Justice in its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 filed with the SEC. The Company revealed that it had received a Civil Investigative Demand on January 11, 2024 for “documents and information relating to a variety of subjects, including practices and procedures related to utilization review, inpatient admissions and inpatient dialysis at [the Company’s] hospitals.” On this news, the price of Community Health shares declined by $1.14 per share, or approximately 28.2%, from $4.04 per share on February 20, 2024 to close at $2.90 per share on February 21, 2024.

If you purchased or otherwise acquired Community Health securities, have information, or would like to learn more about this investigation, contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or by filling out this CONTACT FORM, to discuss your rights or interests with respect to these matters without any cost to you.

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com

Kirby McInerney LLP

NASDAQ:CYH

Release Versions
$Cashtags

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com

More News From Kirby McInerney LLP

ARQ, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Arq, Inc. (“Arq” or the “Company”) (NASDAQ:ARQ). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On March 9, 2026, Arq announced that it decided to “pause GAC production to conduct a comprehensive engineering and...

STELLANTIS N.V. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Stellantis N.V. (“Stellantis” or the “Company”) (NYSE:STLA). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On February 6, 2026, Stellantis “announced that as part of the reset of its business and as it prepares...

INVESTOR ALERT: Securities Class Action Filed Against Oddity Tech Ltd. – Investors Encouraged to Contact Kirby McInerney LLP

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Oddity Tech Ltd. (“Oddity” or the “Company”) (NASDAQ:ODD) securities during the period of February 26, 2025 through February 24, 2026, inclusive (“the Class Period”). If you suffered a loss on your Oddity investments, you have until May 11, 2026 to request lead plaintiff appointment. Courts do not consider lead plaintiff applications submitted a...
Back to Newsroom